Global Sickle Cell Information and Market Trend: Industry Analysis & Outlook (2020-2030)
"Global
Sickle Cell Market: Industry Analysis & Outlook (2020-2030)"
The Report covers current Industries Trends, Worldwide Analysis,
Global Forecast, Review, Share, Size, Growth, Effect.
Description-
Sickle
Cell (SC) is a genetic blood disorder caused by inheriting abnormal
hemoglobin (Hb) genes from parents. Normally, red blood cells (RBC)
have disc-like shapes which help them to travel throughout the blood
vessels. But in the case of SC, red blood cells of a person’s blood
take an abnormal sickle-like shape. Due to SC, red blood cells become
sticky and inelastic. These RBCs block the blood circulation in
different parts of body by getting blocked in the small blood
vessels. Red blood cells live for about 120 days but these sickle
cells live for only 10-20 days. There are various types of sickle
cell disorders caused by different mutations in hemoglobin genes.
Although, all types of sickle cell disorder have similar symptoms but
they differ in their severity and nature of occurrence.
Get
Sample
Report
With TOC @
http://www.researchmoz.us/enquiry.php?type=S&repid=1273864
Currently,
sickle cell is affecting approximately 20 to 25 million people
worldwide and approximately 300 thousand births occur with sickle
cell annually. Sickle cell has a high concentration rate in malaria
endemic parts of worlds, especially, African, Middle Eastern and
South Asian regions. In many African countries, 10% to 40% population
carries sickle cell traits.
The U.S. is expected to be the first region to
start the selling of sickle cell drugs due to developing drug
therapies and later on, market penetration of sickle cell drugs would
occur in Europe.
The global sickle cell market is expected to grow
in future due to rising African-American population, economic growth,
increasing healthcare expenditure and prevalence of sickle cell. Key
trends of this market include progressing drug pipeline and rising
research grants. However, there are some factors which can hinder
growth of the market including regulatory changes, associated risks
and slow adoption of treatments.
The report “Global Sickle Cell Market: Industry
Analysis & Outlook (2020-2030)” by Koncept Analytics provides
an extensive research and detailed analysis of the present market
along with future outlook. The report discusses the major growth
drivers and challenges of the market, covering the U.S, and Europe
along with the global market. The report profiles key players of the
market including Novartis, Bristol-Myers Squibb, Shire Plc, Bluebird
Bio and Global Blood Therapeutics Inc.
-
Table
of Content
1. Overview
1.1 Sickle Cell
1.2 Types of Sickle Cell
1.3 Symptoms & Diagnosis
1.4 Treatment
2. Global Market
2.1 Global Sickle Cell Drug Market Forecast by Value
2.2 Sickle Cell Drug Market by Region
3. Regional Market
3.1 The U.S.
3.1.1 The U.S. Sickle Cell Drug Market Forecast by Value
3.1.2 The U.S. Sickle Cell Patient Volume Forecast
3.1.3 The U.S. Sickle Cell Treated Patient Volume Forecast
3.1.4 The U.S. Sickle Cell Market Forecast by Treatment Cost
3.2 Europe
3.2.1 Europe Sickle Cell Drug Market Forecast by Value
3.2.2 Europe Sickle Cell Patient Volume Forecast
3.2.3 Europe Sickle Cell Treated Patient Volume Forecast
3.2.4 Europe Sickle Cell Market Forecast by Treatment Cost
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Rising American-African Population
4.1.2 Rising Economic Growth
4.1.3 Increasing Healthcare Expenditure
4.1.4 Increasing Prevalence of Sickle Cell
4.2 Key Trends
4.2.1 Progressing Drug Pipeline
4.2.2 Rising Research Grants
4.3 Challenges
4.3.1 Regulatory Challenges
4.3.2 Associated Risks
4.3.3 Slow Adoption of Treatment
5. Competition
5.1 Global Market
5.1.1 Revenue Comparison of Key Players
5.1.2 Market Cap Comparison of Key Players (2016)
6. Company Profiles
6.1 Novartis
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
6.2 Bristol-Myers Squibb
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
6.3 Shire Plc.
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies
6.4 Bluebird Bio
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies
6.5 Global Blood Therapeutics Inc.
6.5.1 Business Overview
6.5.2 Financial Overview
6.5.3 Business Strategies
1.1 Sickle Cell
1.2 Types of Sickle Cell
1.3 Symptoms & Diagnosis
1.4 Treatment
2. Global Market
2.1 Global Sickle Cell Drug Market Forecast by Value
2.2 Sickle Cell Drug Market by Region
3. Regional Market
3.1 The U.S.
3.1.1 The U.S. Sickle Cell Drug Market Forecast by Value
3.1.2 The U.S. Sickle Cell Patient Volume Forecast
3.1.3 The U.S. Sickle Cell Treated Patient Volume Forecast
3.1.4 The U.S. Sickle Cell Market Forecast by Treatment Cost
3.2 Europe
3.2.1 Europe Sickle Cell Drug Market Forecast by Value
3.2.2 Europe Sickle Cell Patient Volume Forecast
3.2.3 Europe Sickle Cell Treated Patient Volume Forecast
3.2.4 Europe Sickle Cell Market Forecast by Treatment Cost
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Rising American-African Population
4.1.2 Rising Economic Growth
4.1.3 Increasing Healthcare Expenditure
4.1.4 Increasing Prevalence of Sickle Cell
4.2 Key Trends
4.2.1 Progressing Drug Pipeline
4.2.2 Rising Research Grants
4.3 Challenges
4.3.1 Regulatory Challenges
4.3.2 Associated Risks
4.3.3 Slow Adoption of Treatment
5. Competition
5.1 Global Market
5.1.1 Revenue Comparison of Key Players
5.1.2 Market Cap Comparison of Key Players (2016)
6. Company Profiles
6.1 Novartis
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
6.2 Bristol-Myers Squibb
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
6.3 Shire Plc.
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies
6.4 Bluebird Bio
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies
6.5 Global Blood Therapeutics Inc.
6.5.1 Business Overview
6.5.2 Financial Overview
6.5.3 Business Strategies
- List of Table
Sickle Cell Prevalence
Drugs in Development (2016)
Bluebird Bio’s Product Pipeline
Drugs in Development (2016)
Bluebird Bio’s Product Pipeline
- List of Chart
Types of Sickle Cell
Sickle Cell Treatments
Global Sickle Cell Drug Market Forecast by Value (2020-2030)
Global Sickle Cell Drug Market by Region (2020/2025/2030
The U.S. Sickle Cell Drug Market Forecast by Value (2020-2030)
The U.S. Sickle Cell Patient Volume Forecast (2020-2030)
The U.S. Sickle Cell Treated Patient Volume Forecast (2020-2030)
The U.S. Sickle Cell Market Forecast by Treatment Cost (2020-2030)
Europe Sickle Cell Drug Market Forecast by Value (2021-2030)
Europe Sickle Cell Patient Volume Forecast (2021-2030)
Europe Sickle Cell Treated Patient Volume Forecast (2021-2030)
Europe Sickle Cell Market Forecast by Treatment Cost (2021-2030)
African-American Population (2012-2016)
Global GDP per Capita (2012-2016)
Global Healthcare Expenditure (2012-2016)
Revenue Comparison of Key Players (2016
Sickle Cell Treatments
Global Sickle Cell Drug Market Forecast by Value (2020-2030)
Global Sickle Cell Drug Market by Region (2020/2025/2030
The U.S. Sickle Cell Drug Market Forecast by Value (2020-2030)
The U.S. Sickle Cell Patient Volume Forecast (2020-2030)
The U.S. Sickle Cell Treated Patient Volume Forecast (2020-2030)
The U.S. Sickle Cell Market Forecast by Treatment Cost (2020-2030)
Europe Sickle Cell Drug Market Forecast by Value (2021-2030)
Europe Sickle Cell Patient Volume Forecast (2021-2030)
Europe Sickle Cell Treated Patient Volume Forecast (2021-2030)
Europe Sickle Cell Market Forecast by Treatment Cost (2021-2030)
African-American Population (2012-2016)
Global GDP per Capita (2012-2016)
Global Healthcare Expenditure (2012-2016)
Revenue Comparison of Key Players (2016
Full
Report @
http://www.researchmoz.us/global-sickle-cell-market-industry-analysis-outlook-20202030-report.html
Comments
Post a Comment